David Shaw’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-65,743
Closed -$27.6K 5033
2022
Q4
$27.6K Sell
65,743
-102,343
-61% -$103K ﹤0.01% 4493
2022
Q3
$164K Buy
168,086
+13,119
+8% +$23.2K ﹤0.01% 4518
2022
Q2
$451K Sell
154,967
-74,673
-33% -$314K ﹤0.01% 4152
2022
Q1
$1.73M Buy
229,640
+119,816
+109% +$992K ﹤0.01% 3442
2021
Q4
$1.53M Buy
109,824
+58,377
+113% +$1.15M ﹤0.01% 3587
2021
Q3
$1.33M Buy
+51,447
New +$1.63M ﹤0.01% 3383

Other funds holding AMTI

David Shaw's AMTI Position: Q1 2023 in Review

David Shaw sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q1 2023, closing a stake of 65,743 shares — an estimated $27.6K sold.

David Shaw first reported a position in AMTI in Q3 2021 and held it in 6 quarters. The position peaked at $1.73M in Q1 2022. 35 funds tracked by Wall St. Rank hold AMTI as of Q1 2023.

  • David Shaw reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • David Shaw sold 65,743 Applied Molecular Transport Inc. Common Stock shares in Q1 2023, an estimated $27.6K.
  • David Shaw first reported a position in Applied Molecular Transport Inc. Common Stock in Q3 2021 and held it in 6 quarters.
  • David Shaw's Applied Molecular Transport Inc. Common Stock position peaked at $1.73M in Q1 2022.
  • 35 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.